Shine-On BioMedical Co.,Ltd.
Taipei Exchange 6926.TWO
Shine-On BioMedical Co.,Ltd. Revenue for the year ending December 31, 2023: USD 310.23 K
Shine-On BioMedical Co.,Ltd. Revenue is USD 310.23 K for the year ending December 31, 2023, a 0.00% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
-
Shine-On BioMedical Co.,Ltd. Revenue for the year ending December 31, 2022 was USD 0.00, a 0.00% change year over year.
-
Shine-On BioMedical Co.,Ltd. Revenue for the year ending December 31, 2021 was USD 0.00.
Key data
| Date | Revenue | Gross Profit | Operating Income | EBIT |
|---|
Market news
Loading...
Taipei Exchange: 6926.TWO
| CEO | Mr. Hongzhe Jiang |
| IPO Date | Nov. 25, 2022 |
| Location | |
| Headquarters | No. 633, Taiwan Avenue |
| Employees | 19 |
| Sector | Health Care |
| Industries | |
Description
Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. The company was founded in 2021 and is based in Taichung, Taiwan.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email